IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
 
BioLegend Homepage Banner
Single-Cell Multiomics and COVID-19
Host immune responses play a central role in controlling SARS-CoV-2 infection, but remain incompletely characterized. Join us for a webinar to hear how Dr. Yapeng Su, recently published in Cell, used an integrated analysis of clinical measurements, immune cells, and plasma multiomics to identify a shift between mild and moderate disease. By condensing over 120,000 immune features into a single axis, Dr. Su and colleagues captured how different immune cells coordinate in response to COVID-19.
Image of Yapeng Su, Ph.D.
Single-Cell Multiomics Resolves A Sharp Disease-State Shift Between Mild and Moderate COVID-19
Speaker: Yapeng Su, Ph.D.
Research Scientist
Leroy Hood Lab, Institute for Systems Biology

Wednesday, February 17, 2021
11 AM PST/2 PM EST
Register Now
 
ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account